Walter Fiona M, Birt Linda, Cavers Debbie, Scott Suzanne, Emery Jon, Burrows Nigel, Cavanagh Gina, MacKie Rona, Weller David, Campbell Christine
The Primary Care Unit, University of Cambridge, Cambridge, UK General Practice and Primary Care Academic Centre, University of Melbourne, Melbourne, Australia.
The Primary Care Unit, University of Cambridge, Cambridge, UK.
BMJ Open. 2014 Jul 21;4(7):e005566. doi: 10.1136/bmjopen-2014-005566.
To explore symptom appraisal and help-seeking decisions among patients recently diagnosed with melanomas, and to compare experiences of people with 'thinner' (<1 mm) and 'thicker' (>2 mm) melanomas, as thickness at diagnosis is an important prognostic feature.
In-depth interviews with patients within 10 weeks of melanoma diagnosis explored the factors impacting on their pathways to diagnosis. Framework analysis, underpinned by the Model of Pathways to Treatment, was used to explore the data with particular focus on patients' beliefs and experiences, disease factors, and healthcare professional (HCP) influences.
63 patients were interviewed (29-93 years, 31 women, 30 thicker melanomas). All described their skin changes using rich lay vocabulary. Many included unassuming features such as 'just a little spot' as well as common features of changes in size, colour and shape. There appeared to be subtly different patterns of symptoms: descriptions of vertical growth, bleeding, oozing and itch were features of thicker melanomas irrespective of pathological type. Appraisal was influenced by explanations such as normal life changes, prior beliefs and whether skin changes matched known melanoma descriptions. Most decisions to seek help were triggered by common factors such as advice from family and friends. 11 patients reported previous reassurance about their skin changes by a HCP, with little guidance on monitoring change or when it would be appropriate to re-consult.
Patients diagnosed with both thinner and thicker melanomas often did not initially recognise or interpret their skin changes as warning signs or prompts to seek timely medical attention. The findings provide guidance for melanoma awareness campaigns on more appropriate images, helpful descriptive language and the need to stress the often apparently innocuous nature of potentially serious skin changes. The importance of appropriate advice, monitoring and safety-netting procedures by HCPs for people presenting with skin changes is also highlighted.
探讨近期被诊断为黑色素瘤的患者的症状评估及寻求帮助的决策,并比较“较薄”(<1毫米)和“较厚”(>2毫米)黑色素瘤患者的经历,因为诊断时的厚度是一个重要的预后特征。
对黑色素瘤诊断后10周内的患者进行深入访谈,探讨影响其诊断途径的因素。采用以治疗途径模型为基础的框架分析来探究数据,特别关注患者的信念和经历、疾病因素以及医疗保健专业人员(HCP)的影响。
共访谈了63名患者(年龄29 - 93岁,31名女性,30例较厚的黑色素瘤)。所有人都用丰富的日常词汇描述了他们的皮肤变化。许多变化包括一些不太起眼的特征,如“只是一个小斑点”,以及大小、颜色和形状变化等常见特征。症状模式似乎存在细微差异:垂直生长、出血、渗出和瘙痒的描述是较厚黑色素瘤的特征,与病理类型无关。评估受到诸如正常生活变化、先前信念以及皮肤变化是否符合已知黑色素瘤描述等解释的影响。大多数寻求帮助的决定是由诸如家人和朋友的建议等常见因素触发的。11名患者报告之前曾得到HCP关于其皮肤变化的安心答复,但关于监测变化或何时再次咨询的指导很少。
被诊断为较薄和较厚黑色素瘤的患者最初往往没有将其皮肤变化识别或解释为警示信号或促使他们及时就医的提示。这些发现为黑色素瘤宣传活动提供了指导,涉及更合适的图像、有用的描述性语言以及强调潜在严重皮肤变化通常看似无害的性质的必要性。还强调了HCP对有皮肤变化的人提供适当建议、监测和安全网程序的重要性。